ReWalk Robotics (RWLK) Misses Q4 EPS by 2c

Go back to ReWalk Robotics (RWLK) Misses Q4 EPS by 2c

ReWalk Robotics Reports Fourth Quarter and Full Year 2022 Financial Results

February 23, 2023 8:00 AM EST

Strong Conclusion to 2022 Q422 Revenue Highest Since Start of COVID-19 Pandemic

Record Quarterly MyoCycle Sales Supplement Improved Exoskeleton Revenue   

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (ReWalk or the Company), a medical device company that designs, develops, and commercializes innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its financial... More